3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
7
Phase NA
4
Phase 2
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
34
Gastrointestinal
4
Thoracic
3
Gynecologic
3
Dermatologic
3
Breast
2
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
618
Head and Neck Neoplasms
598
Nasopharyngeal Carcinoma
230
Thyroid Neoplasms
148
Oropharyngeal Neoplasms
104
Carcinoma, Squamous Cell
89
Salivary Gland Neoplasms
88
Mouth Neoplasms
87
Nasopharyngeal Neoplasms
79
Recurrence
66
Carcinoma, Non-Small-Cell Lung
65
Laryngeal Neoplasms
60
Neoplasm Metastasis
58
Neoplasms
49
Hypopharyngeal Neoplasms
45
Thyroid Carcinoma, Anaplastic
42
Thyroid Cancer, Papillary
42
Melanoma
38
Breast Neoplasms
36
Lung Neoplasms
33
Adenocarcinoma, Follicular
33
Carcinoma
32
Tongue Neoplasms
30
Sarcoma
29
Uterine Cervical Neoplasms
28
Stomatitis
28
Colorectal Neoplasms
28
Carcinoma, Medullary
24
Ovarian Neoplasms
23
Esophageal Neoplasms
23
Interventions
niraparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Urologic Neoplasms
×
Head & Neck
×
Clear all
NCT05169437
2025-10-29
PAVO
Tempus AI
Phase 2
Terminated
22 enrolled
17 charts